Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07286682
PHASE1

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB5285 in Healthy Study Participants

Sponsor: UCB Biopharma SRL

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the safety and tolerability of single ascending doses of UCB5285 in healthy study participants, including healthy Japanese study participants

Official title: A Phase 1, Randomized, Placebo-Controlled Single Ascending Dose Participant- and Investigator-Blind Study to Investigate the Safety, Tolerability, and Pharmacokinetics of UCB5285 in Healthy Study Participants

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

96

Start Date

2025-12-08

Completion Date

2026-12-13

Last Updated

2025-12-23

Healthy Volunteers

Yes

Interventions

DRUG

UCB5285

Participants will receive UCB5285 as prespecified in each cohort.

OTHER

Placebo

Participants will receive matching placebo as prespecified in each cohort.

Locations (1)

Up0161 1001

Harrow, United Kingdom